Evaluation of Droplet Digital PCR Rapid Detection Method and Precise Diagnosis and Treatment for Suspected Sepsis
Key facts
- Who runs it
- Huashan Hospital
- Where
- China9 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 1,032 people enrolled
- Started
- 29 Dec 2021
- Ended
- 29 Dec 2023
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- droplet digital PCR method
- blood culture
- Record updated
- 11 July 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- 1.18 years or older
- 2.Meet 2 of 4 sepsis criteria
- Temperature > 38C or < 36C
- Heart rate > 90 bpm
- Respiratory rate >20 or PaCO2 <32mmHg
- WBC >12000/µL or < 4000/µL or > 10% bands; 3.Hospitalized patients who have a diagnostic blood culture ordered as standard of care for suspected sepsis; 4.Informed Consent by patient or legal representative
Who cannot take part
- Refusal to participate in the study or Failure to comply with treatment or follow-up time
- The researcher believes that there are any conditions (social or medical) that allow subjects to participate is unsafe. For example, severe anemia or high risk of bleeding,etc., which are not suitable for taking peripheral blood for testing
- Known breastfeeding or pregnancy
- Participating in other clinical studies
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Sepsis is a significant public health concern worldwide, with high morbidity and mortality. With regard to a targeted antimicrobial treatment strategy, the earliest possible pathogen detection is of crucial importance. Until now, culture-based detection methods represent the diagnostic gold standard, although they are characterized by numerous limitations. Culture-independent molecular diagnostic procedures may represent a promising alternative. In particular, droplet digital PCR (ddPCR) is a novel one-step PCR assay that achieves higher accuracy and sensitivity in detecting causing pathogens in patients with bloodstream infections.
The 2 groups in the trial
- droplet digital PCR methodTreatment being tested
Pathogen detection by droplet digital PCR method as an adjunct to traditional microbiological assessments including blood culture
- blood culture onlyExisting treatment, for comparison
Pathogen detection by microbiological assessments including blood culture
Treatment: blood culture
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Diagnostic performance and antibiotic impact of droplet digital PCR in suspected sepsis: the PROGRESS trial.Nature communications, 2026
- Prognostic value of poly-microorganisms detected by droplet digital PCR and pathogen load kinetics in sepsis patients: a multi-center prospective cohort study.Microbiology spectrum, 2024
- Evaluation of droplet digital PCR rapid detection method and precise diagnosis and treatment for suspected sepsis (PROGRESS): a study protocol for a multi-center pragmatic randomized controlled trial.BMC infectious diseases, 2022
- Record updated
- 11 July 2025